Angeles Investment Advisors LLC Trims Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Angeles Investment Advisors LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 456 shares of the medical equipment provider’s stock after selling 41 shares during the quarter. Angeles Investment Advisors LLC’s holdings in Intuitive Surgical were worth $238,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in shares of Intuitive Surgical by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after purchasing an additional 360,591 shares during the last quarter. State Street Corp grew its position in Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares during the last quarter. FMR LLC increased its stake in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the period. Geode Capital Management LLC raised its position in Intuitive Surgical by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after buying an additional 143,440 shares during the last quarter. Finally, Fisher Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 1.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after acquiring an additional 86,488 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 269 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at $1,936,380. This represents a 7.58 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 33,754 shares of company stock worth $17,691,621. Insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on ISRG. Citigroup raised their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Truist Financial dropped their price objective on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a report on Monday, March 17th. BTIG Research boosted their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Jefferies Financial Group boosted their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Finally, Barclays increased their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $508.58 on Tuesday. The company has a market cap of $181.15 billion, a PE ratio of 79.34, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The company has a 50-day simple moving average of $561.62 and a 200-day simple moving average of $532.25. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.